LumiraDx Limited (LMDXW) は上場企業です ヘルスケア セクターの Medical - Diagnostics & Research 業界で事業展開. 本社所在地は London, イギリス. 現CEOは Veronique Ameye EMBA,.
LMDXW を有する IPO日 2021-09-29, 1,210 名の正社員, に上場 NASDAQ Global Market, 時価総額 $5.1M.
LumiraDx Limited operates as a point of care diagnostic company. It focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. The company was formerly known as Point of Care Testing Limited and changed its name to LumiraDx Ltd in January 2018. LumiraDx Limited was incorporated in 2002 and is based in London, the United Kingdom.
